Lisocabtagene Maraleucel, Nivolumab and Ibrutinib for the Treatment of Richter's Transformation — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(2 sites)
United States
City of Hope Medical Center, Duarte, California Memorial Sloan Kettering Cancer Center, New York, New York Last updated December 2025